Intake
Clinical history, current medications, and metabolic context.
Tirzepatide and Semaglutide protocols, prescribed and titrated by licensed clinicians. Bloodwork-anchored, dosed for tolerance, and reviewed every cycle.
Appetite, satiety, and metabolic rate are governed by hormonal signals — not motivation. GLP-1s work on those signals directly.
Quick-script clinics push the highest tolerated dose. The result is side-effect attrition and poor long-term adherence.
Slower titration, baseline metabolic panel, and ongoing clinician check-ins keep therapy effective and tolerable.
Lower-attrition titration schedules vs. high-dose start protocols.
Members track waist circumference and lean mass, not just total weight.
Maintenance and de-prescribing pathway built into the protocol from week one.
The clinician recommends a starting agent based on your panel, history, and tolerance profile. Both are available; neither is auto-selected.
Loss varies. We optimize for adherence and composition — not the fastest scale drop. Members typically begin to see change in the first cycle.
Every protocol begins with a 30-minute consult, a clinical history review, and a baseline panel read by a licensed clinician. No medication ships without that review.
REVRCEL operates across the United States through licensed telemedicine clinicians. Available states are confirmed during your intake.
Consultations are non-refundable once completed. Unshipped product orders may be cancelled in full. See our refund policy for the complete terms.
A clinician will review your goals and reply within one business day. Eligibility is established during a 30-minute consult — no PHI is collected on this form.
These statements have not been evaluated by the Food and Drug Administration. Products and protocols are not intended to diagnose, treat, cure, or prevent any disease. Therapy requires evaluation by a licensed clinician. Medical disclosure.